Foetal steroid binding protein and malignancy

Forbes, A ORCID: https://orcid.org/0000-0001-7416-9843 (1987) Foetal steroid binding protein and malignancy. Anticancer Research, 7 (5B). pp. 937-41. ISSN 0250-7005

Full text not available from this repository. (Request a copy)

Abstract

Foetal steroid binding protein (FSBP) is a normal constituent of adult human serum; in vivo it appears to influence the degree of steroid binding to albumin rather than acting primarily as a high affinity saturable binding protein. Serum levels are elevated in patients with parenchymal liver disease, hepatic malignancy and in those with non-metastatic breast cancer. That FSBP is protective against the development of breast carcinoma is however supported by a comparison of healthy women from racial groups at differing risk of this malignancy in which higher levels are found in those at lower risk. This hypothesis and the possible links between FSBP and primary hepatocellular carcinoma are further examined.

Item Type: Article
Uncontrolled Keywords: breast neoplasms,carcinoma, hepatocellular,carrier proteins,female,fetal proteins,humans,liver cirrhosis,liver neoplasms,male,sdg 3 - good health and well-being ,/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being
Faculty \ School: Faculty of Medicine and Health Sciences > Norwich Medical School
UEA Research Groups: Faculty of Medicine and Health Sciences > Research Groups > Gastroenterology and Gut Biology
Faculty of Medicine and Health Sciences > Research Groups > Nutrition and Preventive Medicine
Depositing User: Pure Connector
Date Deposited: 06 Aug 2014 10:44
Last Modified: 24 Oct 2022 23:59
URI: https://ueaeprints.uea.ac.uk/id/eprint/49507
DOI:

Actions (login required)

View Item View Item